Jenburkt Pharmaceuticals Limited (BOM:524731)

India · Delayed Price · Currency is INR

1,019.25

+8.50 (0.84%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Formulations	1.52B	1.42B	1.37B	1.24B	1.09B
Pharmaceutical Formulations Growth	6.85%	3.82%	10.30%	13.44%	-8.07%
Total	1.52B	1.42B	1.37B	1.24B	1.09B
Total Growth	6.85%	3.82%	10.30%	13.44%	-8.07%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	1.32B	1.22B	1.11B	1.03B	874.25M
India Growth	8.80%	9.67%	7.96%	17.48%	-15.05%
Exports	190.48M	200.23M	252.58M	210.26M	214.44M
Exports Growth	-4.87%	-20.73%	20.13%	-1.95%	41.72%
Total	1.51B	1.42B	1.36B	1.24B	1.09B
Total Growth	6.87%	4.03%	10.03%	13.65%	-7.77%

Source: S&P Global Market Intelligence.